
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows. People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (Ozempic, Wegovy), researchers reported July 8 in the journal JAMA Internal Medicine. “Individuals with overweight or obesity treated with tirzepatide were significantly more likely to achieve clinically meaningful weight loss… read on > read on >